12/1
06:03 pm
ctkb
Cytek Biosciences (NASDAQ:CTKB) was given a new $6.00 price target on by analysts at Morgan Stanley.
Low
Report
Cytek Biosciences (NASDAQ:CTKB) was given a new $6.00 price target on by analysts at Morgan Stanley.
11/20
05:50 am
ctkb
Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth [Seeking Alpha]
Low
Report
Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth [Seeking Alpha]
11/17
04:43 am
ctkb
Cytek Biosciences (CTKB): Evaluating Valuation After TIME's 2026 Growth Leaders Recognition and Recurring Revenue Momentum [Yahoo! Finance]
High
Report
Cytek Biosciences (CTKB): Evaluating Valuation After TIME's 2026 Growth Leaders Recognition and Recurring Revenue Momentum [Yahoo! Finance]
11/12
05:06 pm
ctkb
TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026 [Yahoo! Finance]
Medium
Report
TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026 [Yahoo! Finance]
11/12
05:00 pm
ctkb
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
Medium
Report
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
11/11
12:21 pm
ctkb
Cytek Biosciences (NASDAQ:CTKB) had its price target lowered by analysts at Piper Sandler from $8.00 to $7.50. They now have an "overweight" rating on the stock.
Low
Report
Cytek Biosciences (NASDAQ:CTKB) had its price target lowered by analysts at Piper Sandler from $8.00 to $7.50. They now have an "overweight" rating on the stock.
11/6
06:10 pm
ctkb
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year [Yahoo! Finance]
Low
Report
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year [Yahoo! Finance]
11/6
05:00 pm
ctkb
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
Medium
Report
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
11/6
04:05 pm
ctkb
Cytek Biosciences to Participate in Upcoming Investor Conferences
Medium
Report
Cytek Biosciences to Participate in Upcoming Investor Conferences
11/6
06:56 am
ctkb
Cytek Biosciences (NASDAQ:CTKB) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Cytek Biosciences (NASDAQ:CTKB) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
11/5
04:05 pm
ctkb
Cytek Biosciences Reports Third Quarter 2025 Financial Results
High
Report
Cytek Biosciences Reports Third Quarter 2025 Financial Results
10/29
05:00 pm
ctkb
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
Medium
Report
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
10/22
04:35 pm
ctkb
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025 [Yahoo! Finance]
Low
Report
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025 [Yahoo! Finance]
10/22
04:05 pm
ctkb
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025
Low
Report
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025
10/15
05:00 pm
ctkb
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
Low
Report
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
9/12
07:21 am
ctkb
How To Embed Emotional Intelligence Into Your Culture [Forbes]
Medium
Report
How To Embed Emotional Intelligence Into Your Culture [Forbes]
9/10
05:20 pm
ctkb
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA [Yahoo! Finance]
High
Report
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA [Yahoo! Finance]
9/10
05:00 pm
ctkb
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
High
Report
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA